Dysbiosis Drives Digestive Distress

Recent human studies from 2020 to 2024 paint a compelling picture of how gut dysbiosis fuels gastrointestinal woes like bloating, diarrhea, and abdominal pain. Across diverse conditions—ranging from IBS and SIBO to IBD and even COVID-19—research consistently reveals a microbial mayhem marked by slashed diversity and skewed bacterial balance. Beneficial bugs like Faecalibacterium, Bacteroides, and Bifidobacterium take a hit, while troublemakers such as Proteobacteria and Enterobacteriaceae, species muscle in, amplifying symptoms and inflammation. Whether it’s a cross-sectional snapshot or a longitudinal trek through flare-ups, the evidence is clear: an imbalanced gut microbiome isn’t just a bystander—it’s a key player in digestive distress, spotlighting a microbial frontier ripe for intervention.